AEON Biopharma, Inc.
AEON · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $21,009 | $39,954,125 | $202,364 | $202,364 |
| - Cash | $13 | $5,158 | $9,746 | $5,128 |
| + Debt | $12,955 | $278 | $131,534 | $86,889 |
| Enterprise Value | $33,951 | $39,949,245 | $324,152 | $284,125 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$27,727 | -$52,737 | -$48,361 | -$36,878 |
| % Margin | – | – | – | – |
| Net Income | $42,005 | -$384,632 | -$52,556 | -$55,637 |
| % Margin | – | – | – | – |
| EPS Diluted | 72.93 | -4.99 | -27.25 | -31.73 |
| % Growth | 1,561.5% | 81.7% | 14.1% | – |
| Operating Cash Flow | -$20,292 | -$47,825 | -$35,584 | -$28,433 |
| Capital Expenditures | $0 | $0 | -$306 | -$170 |
| Free Cash Flow | -$20,292 | -$47,825 | -$35,890 | -$28,603 |